Our Pipeline
Category: Page block
This category indicates a piece on a page. This is not content that will be used throughout the website. A page block is a piece of content on a certain page, and you can edit it via this category
Yselty – Uterine Fibroids
Commercial Rights ObsEva holds U.S. and Canadian rights Kissei holds Asian rights Exclusive worldwide rights outside of the U.S., Canada,…
Linzagolix landing image

Our pipeline
Ebopiprant Collaborations

In July 2021, Obseva licensed the exclusive worldwide rights to develop, manufacturing and commercial rights to ebopiprant (OBE022) to Organon,…
HCW Presentation September 13, 2021
Canaccord Presentation August 12, 2021
Wedbush Presentation August 11, 2021
HCW Presentation March 9, 2021
SVB Leerink Presentation Feb 24, 2021
Linzagolix EM
(OBE2109)
Oral GnRH
receptor antagonist